Cancer Treatment Doctor in Jaipur: Dr Ruchir Bhandari
About Me
INTRODUCTION
My experience & training in cancer care
An accomplished physician with over 13 years of experience in Clinical Oncology, I possess distinguished academic credentials, including FRCR(UK), ESMO certification, MD, and DNB in oncology, and am currently working as a Senior Consultant at Mahatma Gandhi Medical College & Hospital, Jaipur. I have previously worked and trained in the NHS, UK in some of the world’s leading cancer centers and been trained in the latest cancer therapies and radiotherapy techniques. As a former Consultant and Head at Manipal Hospitals and Apex Hospitals, Jaipur from 2015 to 2021, I bring a unique blend of clinical and administrative experience. I have received training from esteemed institutions such as SMS Jaipur and Safdarjung Hospital Delhi, complemented by three years of dedicated research and teaching experience at AIIMS Delhi.
I am Rajasthan’s first Clinical Oncologist and the only one to be formally trained in Stereotactic Radiosurgery techniques. I bring a wealth of experience in diverse clinical settings and with innovative radiation therapy technologies including SRS/SBRT, IGRT, VMAT, brachytherapy etc. I’ve gained hands-on experience with MR Linac, Cyberknife, Gamma knife, Varian, Elekta, Xstrahl utilizing Exactrac/Vision RT for guidance and motion management and implementing adaptive radiotherapy techniques and PET-based planning.
My vision is to establish a world-class Stereotactic Radiosurgery (SRS) center in India. I am dually trained in delivering both systemic therapies and radiotherapy and only practice evidence-based treatment according to International Guidelines.
In my current role as Clinical Lead & Incharge of the CyberKnife Radiosurgery Unit at Mahatma Gandhi Hospital, I hope to develop a world-class radiotherapy program for radiosurgery for the people of my state, ensuring they have access to cutting-edge treatments that enhance patient outcomes and improve their quality of life.
Feel free to connect with me if you have any questions.
EDUCATION
-
FRCR Clinical Oncology
Fellowship of Royal College of Radiology, UK -
ESMO Certified, Oncology
ESMO, Switzerland -
DNB Radiotherapy
Diplomate National Board, India -
MD Radiotherapy
VMMC & Safdarjung Hospital, New Delhi -
Digital Transformation in Healthcare Innovation, Strategies & Processes
Imperial College Business School -
Certificate course in Essentials of Palliative Care
Indian Association of Palliative Care -
MBBS
Sawai Man Singh Medical College & Hospitals, Jaipur
Dr. Ruchir Bhandari
FRCR(London),MD,DNB
Clinical(Radiation)Oncologist
PAST WORK EXPERIENCE
Clinical Fellowship in MRI Linac & Cyberknife Radiosurgery, Royal Marsden, London : June 2024
Clinical Oncologist, University NHS Hospital, Southampton, UK : March 2023 - May 2024
International Training Fellowship (Clinical Oncology) Derby, UK : July 2021 - Feb 2023
Consultant, Manipal Hospital, Jaipur : Feb 2021 - June 2021
Consultant & Head, Apex Hospital, Jaipur : Dec 2018 - Dec 2020
Consultant & Head, Manipal Hospital, Jaipur : Nov 2015 - Dec 2018
Visiting Fellow, Christie Hospital, Manchester, UK : Sept 2017 - Oct 2017
Senior Registrar, Clinical Oncology and Radiotherapy : Aug 2012 - July 2015
Junior Registrar, Clinical Oncology and Radiotherapy : June 2009 - June 2012
- IGRT / VMAT, SRS/SABR for all tumor sites using KVCT, CBCT & SGRT(Exactrac/Vision RT), ABC / DIBH, etc.
- Brachytherapy, XStrahl LDRT, electron therapy, Total body irradiation, and IOERT.
- Trained in multiple Planning systems. M-vision, BrainLAB, Eclipse, Monaco, Oncentra, Pinnacle, Gamma plan, Prosoma, Plato, ARIA, Mosaiq etc.
- Worked on Versa HD, TrueBeam, Gamma Knife, Cyberknife, X knife, Brachytherapy (Beibig, Gamma med, Microselectron).
- Proficiency in delivering systemic therapies etc
- Pain and palliative care & Preventive oncology
- A retrospective analysis of quality and symmetry of space OAR placement in prostate radiotherapy. A tertiary cancer center experience (July 2022) – under submission.
- A multicenter real-life U.K. study of the use of immunotherapeutic agents in metastatic urothelial cancer. DOI: 10.1200/JCO.2022.40.6_suppl.504 Journal of Clinical Oncology 40, no. 6_suppl (February 20, 2022) 504-504.
- Lung cancer management challenges amidst COVID-19 pandemic: Hope lives here. Future medicine.2020.
- Urinary Dysfunction assessment in long-term survivors of carcinoma cervix using LENT – SOMA scale: an Indian study addressing Quality of life issues. Asian Pacific journal of cancer prevention: APJCP 20 (2), 383.
- Role of palliative radiotherapy, chemotherapy, and stents for dysphagia and quality of life improvement in advanced esophageal cancer. The optimal management? Annals of Oncology, Volume 28, Issue suppl_3, 1 June 2017.
- Contra lateral breast cancer: a clinicopathological study of second primaries in opposite breasts after treatment of breast malignancy. Asian Pac J Cancer Prev. 2015;16(3):1207-11.
- Level of awareness of lung cancer risk factors, signs, symptoms, and safe practices among college
teachers of different states in India: Do awareness programs have an impact on the adoption of safe practices? October 2015, The Gulf journal of oncology, 1(19):57-62 - Role of palliative radiotherapy, chemotherapy, and stents for dysphagia and quality of life improvement in advanced esophageal cancer. The optimal management? Annals of Oncology 28 (suppl_3). 2017.
- Concurrent chemoradiation with cisplatin in locally advanced head and neck squamous cell carcinoma: AROICON, Jaipur 2012.
- Oral presentation on nutritional aspects during chemoradiation of head & neck cancers: ANEMECON, Nepal 2013.
- Comparison of weekly versus three-weekly concurrent chemoradiation with cisplatin in locally advanced Head and Neck squamous cell carcinoma: postgraduate Thesis, 2012.
- Registered with General Medical Council GMC/7892397
- Registered with the Royal College of Radiology (RCR, UK) – RCR/319473
- Registered with Delhi Medical Council – DMC/47100.
- Registered with Rajasthan Medical Council – RMC/26842
- Member, Association of Radiation Oncology of India ( Regd No. 1458)
- Member, European Society of Medical Oncology (ESMO) (Regd no. 81853)
- Member, International Society of Stereotactic Radiosurgery
- Member, European Society of Therapeutic Radiation Oncology
RESEARCH AND PUBLICATION
- Contra lateral breast cancer: a clinicopathological study of second primaries in opposite breasts after treatment of breast malignancy. Asian Pac J Cancer Prev. 2015;16(3):1207-11.
- Level of awareness of lung cancer risk factors, signs, symptoms, and safe practices among college
teachers of different states in India: Do awareness programs have an impact on the adoption of safe practices? October 2015, The Gulf journal of oncology, 1(19):57-62 - Role of palliative radiotherapy, chemotherapy, and stents for dysphagia and quality of life improvement in advanced esophageal cancer. The optimal management? Annals of Oncology 28 (suppl_3). 2017.
- Concurrent chemoradiation with cisplatin in locally advanced head and neck squamous cell carcinoma: AROICON, Jaipur 2012.
- Oral presentation on nutritional aspects during chemoradiation of head & neck cancers: ANEMECON, Nepal 2013.
- Comparison of weekly versus three-weekly concurrent chemoradiation with cisplatin in locally advanced Head and Neck squamous cell carcinoma: postgraduate Thesis, 2012.
AWARDS AND FELLOWSHIPS
- Travel Grant for ESMO course on EGFR mutant Non-Small Cell Lung cancer, Oct 2016, South Korea.
- Travel Grant for ESMO Preceptorship program on prostate cancer, April 2015, Prague, Czechoslovakia.
- Travel Grant for ESMO Preceptorship program on Neuro-endocrine tumors, Nov 2014, Leuven, Belgium.
- Travel Grant for ESMO translational research visit, Karolinska Institute, June 2014, Stockholm, Sweden.
- CSIR-pool Scientist award, Council of Scientific and Industrial Research, Govt of India, July 2012.
- Travel Grant for Australia and Asia Pacific Clinical Oncology Research Development (ACORD) Fellowship,
Sept 2012, Brisbane. - Neal Joseph travel fellowship, Association of Radiation Oncologists of India, Nov 2011, Jaipur.
PROFESSIONAL LICENSE AND MEMBERSHIPS
- Registered with General Medical Council GMC/7892397
- Registered with the Royal College of Radiology (RCR, UK) – RCR/319473
- Registered with Delhi Medical Council – DMC/47100.
- Registered with Rajasthan Medical Council – RMC/26842
- Member, Association of Radiation Oncology of India ( Regd No. 1458)
- Member, European Society of Medical Oncology (ESMO) (Regd no. 81853)
- Member, International Society of Stereotactic Radiosurgery
- Member, European Society of Therapeutic Radiation Oncology
INTERESTS
Areas of interest
CNS, Head & Neck, Urological cancers, Oligometastatic Tumours & Radiosurgery for early cancers.
Vision
To start a world-class Stereotactic Radiosurgery program in Benign and Metastatic tumors.
Mission
Passion to improve Early Cancer detection and improve access to high quality Radiotherapy.